Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Quarterly results
Consulting agrmnt
Director departure
Appointed director
NEPHROS INC (NEPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Nephros, Inc."
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/01/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Nephros Announces CEO Retirement and Succession Plan"
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 ARS Form ARS - Annual Report to Security Holders:
04/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/04/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Nephros Announces Preliminary Results for First Quarter 2023 Net Revenue of $3.7 Million, a 69% Year-Over-Year Increase"
03/23/2023 10-K Annual Report for the period ended December 31, 2022
03/08/2023 8-K Quarterly results
Docs: "Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 nephros.com Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million"
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 8-K Resignation/termination of a director
01/11/2023 8-K Quarterly results
01/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/21/2022 8-K Quarterly results
11/15/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/15/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
11/02/2022 8-K Quarterly results
Docs: "Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 nephros.com Nephros Announces Results for Quarter Ended September 30, 2022"
10/11/2022 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits ...
Docs: "Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022 Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision; Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase 18% YoY"
09/08/2022 8-K Appointed a new director
Docs: "Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 nephros.com Nephros Appoints Joe Harris to Its Board of Directors"
08/23/2022 8-K Quarterly results
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/10/2022 8-K Quarterly results
07/06/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/17/2022 8-K Quarterly results
05/05/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/04/2022 8-K Quarterly results
04/13/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/03/2022 10-K Annual Report for the period ended December 31, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy